About (3S)-5-phenyl-3-[[5-[5-(trifluoromethyl)-3-[2-(trifluoromethyl)morpholin-4-yl]-2-pyridinyl]-1,3,4-oxadiazol-2-yl]amino]-1,3-dihydro-1,4-benzodiazepin-2-one
(3S)-5-phenyl-3-[[5-[5-(trifluoromethyl)-3-[2-(trifluoromethyl)morpholin-4-yl]-2-pyridinyl]-1,3,4-oxadiazol-2-yl]amino]-1,3-dihydro-1,4-benzodiazepin-2-one (PubChem CID 134461562) has the molecular formula C28H21F6N7O3
and a molecular weight of 617.51 g/mol. Its IUPAC name is (3S)-5-phenyl-3-[[5-[5-(trifluoromethyl)-3-[2-(trifluoromethyl)morpholin-4-yl]-2-pyridinyl]-1,3,4-oxadiazol-2-yl]amino]-1,3-dihydro-1,4-benzodiazepin-2-one.
Analyze (3S)-5-phenyl-3-[[5-[5-(trifluoromethyl)-3-[2-(trifluoromethyl)morpholin-4-yl]-2-pyridinyl]-1,3,4-oxadiazol-2-yl]amino]-1,3-dihydro-1,4-benzodiazepin-2-one with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of (3S)-5-phenyl-3-[[5-[5-(trifluoromethyl)-3-[2-(trifluoromethyl)morpholin-4-yl]-2-pyridinyl]-1,3,4-oxadiazol-2-yl]amino]-1,3-dihydro-1,4-benzodiazepin-2-one?
The IUPAC name of (3S)-5-phenyl-3-[[5-[5-(trifluoromethyl)-3-[2-(trifluoromethyl)morpholin-4-yl]-2-pyridinyl]-1,3,4-oxadiazol-2-yl]amino]-1,3-dihydro-1,4-benzodiazepin-2-one (CID 134461562) is (3S)-5-phenyl-3-[[5-[5-(trifluoromethyl)-3-[2-(trifluoromethyl)morpholin-4-yl]-2-pyridinyl]-1,3,4-oxadiazol-2-yl]amino]-1,3-dihydro-1,4-benzodiazepin-2-one.
What is the SMILES notation for (3S)-5-phenyl-3-[[5-[5-(trifluoromethyl)-3-[2-(trifluoromethyl)morpholin-4-yl]-2-pyridinyl]-1,3,4-oxadiazol-2-yl]amino]-1,3-dihydro-1,4-benzodiazepin-2-one?
The canonical SMILES for (3S)-5-phenyl-3-[[5-[5-(trifluoromethyl)-3-[2-(trifluoromethyl)morpholin-4-yl]-2-pyridinyl]-1,3,4-oxadiazol-2-yl]amino]-1,3-dihydro-1,4-benzodiazepin-2-one is O=C1Nc2ccccc2C(c2ccccc2)=N[C@@H]1Nc1nnc(-c2ncc(C(F)(F)F)cc2N2CCOC(C(F)(F)F)C2)o1.
What is the InChIKey of (3S)-5-phenyl-3-[[5-[5-(trifluoromethyl)-3-[2-(trifluoromethyl)morpholin-4-yl]-2-pyridinyl]-1,3,4-oxadiazol-2-yl]amino]-1,3-dihydro-1,4-benzodiazepin-2-one?
The InChIKey is MKVBHKJZJNAARW-GWQXNCQPSA-N. The full InChI is InChI=1S/C28H21F6N7O3/c29-27(30,31)16-12-19(41-10-11-43-20(14-41)28(32,33)34)22(35-13-16)25-39-40-26(44-25)38-23-24(42)36-18-9-5-4-8-17(18)21(37-23)15-6-2-1-3-7-15/h1-9,12-13,20,23H,10-11,14H2,(H,36,42)(H,38,40)/t20?,23-/m1/s1.
What are the key properties of (3S)-5-phenyl-3-[[5-[5-(trifluoromethyl)-3-[2-(trifluoromethyl)morpholin-4-yl]-2-pyridinyl]-1,3,4-oxadiazol-2-yl]amino]-1,3-dihydro-1,4-benzodiazepin-2-one?
(3S)-5-phenyl-3-[[5-[5-(trifluoromethyl)-3-[2-(trifluoromethyl)morpholin-4-yl]-2-pyridinyl]-1,3,4-oxadiazol-2-yl]amino]-1,3-dihydro-1,4-benzodiazepin-2-one has a molecular weight of 617.51 g/mol, XLogP of 5.15, 5 rotatable bonds, 2 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for (3S)-5-phenyl-3-[[5-[5-(trifluoromethyl)-3-[2-(trifluoromethyl)morpholin-4-yl]-2-pyridinyl]-1,3,4-oxadiazol-2-yl]amino]-1,3-dihydro-1,4-benzodiazepin-2-one is sourced from PubChem (CID 134461562), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).